Search

everythinglearnresearchcommunity

for

Search:↓

TTD hair is brittle due to fewer sulfur amino acids and unstable disulfide bonds.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

Spt4 and Spt6 are essential for fat cell development.

Two siblings were diagnosed with Trichothiodystrophy, identified by brittle hair and low sulfur content.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Controlling Tslp can improve health in AEC syndrome patients.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Some thymic peptides can increase human hair growth, while others may inhibit it.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

PRS injections can improve knee function and reduce pain for up to a year.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Trichodysplasia spinulosa can occur after a heart transplant due to immunosuppressive drugs.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

A new compound shows promise as a topical treatment for hair loss.

Increasing TSPO in the brain may help improve memory problems.

SPRY1 deficiency in skin cells causes stem cells to move to the skin surface, leading to increased pigmentation.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.